메뉴 건너뛰기




Volumn 31, Issue 2, 2005, Pages 141-146

Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases

Author keywords

Colorectal liver metastases; Neoadjuvant chemotherapy; Postoperative complications; Resection

Indexed keywords

ANTINEOPLASTIC AGENT;

EID: 13444274825     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.07.030     Document Type: Article
Times cited : (18)

References (15)
  • 1
    • 0346347411 scopus 로고    scopus 로고
    • Liver metastases-primary or multimodal therapy?
    • R. Ott A. Wein W. Hohenberger Liver metastases-primary or multimodal therapy? Chirurg 72 2001 887-897
    • (2001) Chirurg , vol.72 , pp. 887-897
    • Ott, R.1    Wein, A.2    Hohenberger, W.3
  • 3
    • 0033504042 scopus 로고    scopus 로고
    • Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 cases
    • discussion 318-21
    • Y. Fong J. Fortner R.L. Sun M. Brennan L.H. Blumgart Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 cases Ann Surg 230 1999 309-318 discussion 318-21
    • (1999) Ann. Surg. , vol.230 , pp. 309-318
    • Fong, Y.1    Fortner, J.2    Sun, R.L.3    Brennan, M.4    Blumgart, L.H.5
  • 4
    • 0029881854 scopus 로고    scopus 로고
    • Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients
    • B. Nordlinger M. Guiget J.C. Vaillant P. Balladur et al. Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients Cancer 77 1996 1254-1262
    • (1996) Cancer , vol.77 , pp. 1254-1262
    • Nordlinger, B.1    Guiget, M.2    Vaillant, J.C.3    Balladur, P.4
  • 5
    • 0032791959 scopus 로고    scopus 로고
    • Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
    • S. Giacchetti M. Itzhaki G. Gruia et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery Ann Oncol 10 1999 663-669
    • (1999) Ann. Oncol. , vol.10 , pp. 663-669
    • Giacchetti, S.1    Itzhaki, M.2    Gruia, G.3
  • 6
    • 0035698112 scopus 로고    scopus 로고
    • Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid
    • A. Wein C. Riedel W. Hohenberger et al. Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid Ann Oncol 12 2001 1721-1727
    • (2001) Ann. Oncol. , vol.12 , pp. 1721-1727
    • Wein, A.1    Riedel, C.2    Hohenberger, W.3
  • 7
    • 0033874892 scopus 로고    scopus 로고
    • Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
    • A. De Gramont A. Figer M. Seymour et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol 18 2000 2938-2947
    • (2000) J. Clin. Oncol. , vol.18 , pp. 2938-2947
    • De Gramont, A.1    Figer, A.2    Seymour, M.3
  • 8
    • 0033989203 scopus 로고    scopus 로고
    • Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluoruracil-leucovorin as first-line treatment of metastatic colorectal cancer
    • S. Giacchetti B. Perpoint R. Zidani et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluoruracil-leucovorin as first-line treatment of metastatic colorectal cancer J Clin Oncol 18 2000 136-147
    • (2000) J. Clin. Oncol. , vol.18 , pp. 136-147
    • Giacchetti, S.1    Perpoint, B.2    Zidani, R.3
  • 9
    • 0344870269 scopus 로고    scopus 로고
    • Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: Results of EORTC GI Group Study 40986
    • C.H. Kohne E. Van Cutsem B. Nordlinger et al. Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: Results of EORTC GI Group Study 40986 ASCO 22 2003 1018
    • (2003) ASCO , vol.22 , pp. 1018
    • Kohne, C.H.1    Van Cutsem, E.2    Nordlinger, B.3
  • 10
    • 0037256469 scopus 로고    scopus 로고
    • Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer
    • A. Wein C. Riedel W. Hohenberger et al. Neoadjuvant treatment with weekly high-dose 5-Fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer Oncology 64 2003 131-138
    • (2003) Oncology , vol.64 , pp. 131-138
    • Wein, A.1    Riedel, C.2    Hohenberger, W.3
  • 11
    • 0028308472 scopus 로고
    • Factors influencing the natural history of colorectal liver metastases
    • R. Stangl A. Altendorf-Hofmann R.M. Charnley J. Scheele Factors influencing the natural history of colorectal liver metastases Lancet 343 1994 1405-1410
    • (1994) Lancet , vol.343 , pp. 1405-1410
    • Stangl, R.1    Altendorf-Hofmann, A.2    Charnley, R.M.3    Scheele, J.4
  • 12
    • 0029794696 scopus 로고    scopus 로고
    • Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
    • H. Bismuth R. Adam F. Levi et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy Ann Surg 224 1996 509-520
    • (1996) Ann. Surg. , vol.224 , pp. 509-520
    • Bismuth, H.1    Adam, R.2    Levi, F.3
  • 13
    • 0035346978 scopus 로고    scopus 로고
    • Resektion of colorectal liver metastases: Which prognostic factors should govern patient selection?
    • J. Scheele A. Altendorf-Hofmann T. Grube W. Hohenberger R. Stangl K. Schmidt Resektion of colorectal liver metastases: Which prognostic factors should govern patient selection? Chirurg 72 2001 547-560
    • (2001) Chirurg , vol.72 , pp. 547-560
    • Scheele, J.1    Altendorf-Hofmann, A.2    Grube, T.3    Hohenberger, W.4    Stangl, R.5    Schmidt, K.6
  • 14
    • 0000357764 scopus 로고    scopus 로고
    • Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery
    • Nordlinger B, Jaeck D (eds). New York: Springer, Berlin, Heidelberg
    • Nordlinger B, Jaeck D, Guiguet M, Vaillant JC, Balladur P, Schaal J. Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery. In: Nordlinger B, Jaeck D (eds). Treatment of hepatic metastases of colorectal cancer. New York: Springer, Berlin, Heidelberg; 1998. p. 129-46.
    • (1998) Treatment of Hepatic Metastases of Colorectal Cancer , pp. 129-146
    • Nordlinger, B.1    Jaeck, D.2    Guiguet, M.3    Vaillant, J.C.4    Balladur, P.5    Schaal, J.6
  • 15
    • 0028858987 scopus 로고
    • Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors
    • D. Elias P. Lasser P. Rougier M. Ducreux C. Bognel A. Roche Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors J Am Coll Surg 180 1995 213-219
    • (1995) J. Am. Coll. Surg. , vol.180 , pp. 213-219
    • Elias, D.1    Lasser, P.2    Rougier, P.3    Ducreux, M.4    Bognel, C.5    Roche, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.